ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of …

FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) (‘Company’), a clinical-stage biopharmace.

Do you trust this headline?

Based on recent headline ratings, 57% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending negative.


Media Trust Score57%